EVK Stock Analysis: Evonik Industries | XETRA
Specialty Chemicals | XETRA, Germany | Market Cap: 8.845m EUR | 12M Return: 23.2% | DE000EVNK013 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.3M
EPS Trend: 47.9%
Qual. Beats: 1
Rev. Trend: -91.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Evonik Industries AG is a German specialty chemicals company headquartered in Essen, founded in 1847. It operates globally across Asia-Pacific, Europe, the Middle East, Africa, and the Americas through three reporting segments: Advanced Technologies, Custom Solutions, and Infrastructure.
The Advanced Technologies segment supplies performance chemicals such as medical-grade polymers, hydrogen peroxide (used in semiconductor wafer cleaning and pulp/paper bleaching), specialty silicas and silanes for tires, electronics, and cosmetics, and the essential amino acids D-/L-methionine and lysine for animal feed. Evonik is one of the worlds largest producers of methionine, a key feed additive for poultry and swine, reflecting the companys deep position in life-sciences-oriented specialty chemistry rather than commodity chemicals.
The Custom Solutions segment focuses on functional additives for coatings, adhesives, sealants, polyurethane foams, and lubricants serving cosmetics, cleaning, and pharmaceutical end-markets. The Infrastructure segment supplies C4-based petrochemical intermediates, including butadiene, MTBE, butene-1, isononanol, and DINP, which feed into plastics, packaging, rubber, fuel production, and as plasticizers for the construction and automotive industries.
- Methionine oversupply pressures animal nutrition segment margins
- High European energy costs squeeze German production profitability
- Construction slowdown weakens plasticizer and coatings additives demand
| Net Income: 121.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 2.07 > 1.0 |
| NWC/Revenue: 13.29% < 20% (prev 11.74%; Δ 1.55% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.63b > Net Income 121.0m |
| Net Debt (4.94b) to EBITDA (2.11b): 2.34 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (466.0m) vs 12m ago 0.97% < -2% |
| Gross Margin: 22.18% > 18% (prev 24.69%; Δ -2.51% > 0.5%) |
| Asset Turnover: 74.94% > 50% (prev 77.19%; Δ -2.25% > 0%) |
| Interest Coverage Ratio: 3.69 > 6 (EBIT TTM 796.0m / Interest Expense TTM 216.0m) |
| A: 0.10 (Total Current Assets 5.66b - Total Current Liabilities 3.78b) / Total Assets 18.6b |
| B: 0.37 (Retained Earnings 6.82b / Total Assets 18.6b) |
| C: 0.04 (EBIT TTM 796.0m / Avg Total Assets 18.8b) |
| D: 0.74 (Book Value of Equity 7.87b / Total Liabilities 10.7b) |
| Altman-Z'' = 2.91 = A |
| DSRI: 1.26 (Receivables 1.96b/1.62b, Revenue 14.1b/14.7b) |
| GMI: 1.11 (GM 24.69% / 22.18%) |
| AQI: 0.97 (AQ_t 0.33 / AQ_t-1 0.34) |
| SGI: 0.96 (Revenue 14.1b / 14.7b) |
| TATA: -0.08 (NI 121.0m - CFO 1.63b) / TA 18.6b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of September 05, 2026, the stock is trading at EUR 18.60 with a total of 1,116,099 shares traded. Over the past week, the price has changed by -1.01%, over one month by +4.09%, over three months by +17.95% and over the past year by +23.15%.
Current recommended Stop Loss: 17.90 (which is 3.8% or 1.9 ATR below the current price).
Evonik Industries has no consensus analysts rating.
P/E Trailing = 73.0
P/E Forward = 19.9203
P/S = 0.6267
P/B = 1.1141
P/EG = 6.2284
Revenue TTM = 14.1b EUR
EBIT TTM = 796.0m EUR
EBITDA TTM = 2.11b EUR
Long Term Debt = 2.59b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 748.0m EUR (from shortTermDebt, last quarter)
Debt = 5.33b EUR (from shortLongTermDebtTotal, last quarter) + Leases 865.0m
Net Debt = 4.94b EUR (calculated: Debt 5.33b - CCE 390.0m)
Enterprise Value = 13.8b EUR (8.84b + Debt 5.33b - CCE 390.0m)
Interest Coverage Ratio = 3.69 (Ebit TTM 796.0m / Interest Expense TTM 216.0m)
EV/FCF = 16.29x (Enterprise Value 13.8b / FCF TTM 846.0m)
FCF Yield = 6.14% (FCF TTM 846.0m / Enterprise Value 13.8b)
FCF Margin = 5.99% (FCF TTM 846.0m / Revenue TTM 14.1b)
Net Margin = 0.86% (Net Income TTM 121.0m / Revenue TTM 14.1b)
Gross Margin = 22.18% ((Revenue TTM 14.1b - Cost of Revenue TTM 11.0b) / Revenue TTM)
Gross Margin QoQ = 24.71% (prev 25.21%)
Tobins Q-Ratio = 0.74 (Enterprise Value 13.8b / Total Assets 18.6b)
Interest Expense / Debt = 4.05% (Interest Expense 216.0m / Debt 5.33b)
Taxrate = 30.33% (37.0m / 122.0m)
NOPAT = 554.6m (EBIT 796.0m * (1 - 30.33%))
Current Ratio = 1.50 (Total Current Assets 5.66b / Total Current Liabilities 3.78b)
Debt / Equity = 0.68 (Debt 5.33b / totalStockholderEquity, last quarter 7.87b)
Debt / EBITDA = 2.34 (Net Debt 4.94b / EBITDA 2.11b)
Debt / FCF = 5.84 (Net Debt 4.94b / FCF TTM 846.0m)
Total Stockholder Equity = 8.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.64% (Net Income 121.0m / Total Assets 18.6b)
RoE = 1.49% (Net Income TTM 121.0m / Total Stockholder Equity 8.14b)
RoCE = 7.42% (EBIT 796.0m / Capital Employed (Equity 8.14b + L.T.Debt 2.59b))
RoIC = 3.65% (NOPAT 554.6m / Invested Capital 15.2b)
WACC = 4.75% (E(8.84b)/V(14.2b) * Re(5.91%) + D(5.33b)/V(14.2b) * Rd(4.05%) * (1-Tc(0.30)))
Discount Rate = 5.91% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 3.36 | Cagr: 0.0%
[DCF] Terminal Value 77.97% ; FCFF base≈696.4m ; Y1≈798.3m ; Y5≈1.17b
[DCF] Fair Price = 27.34 (EV 17.7b - Net Debt 4.94b = Equity 12.7b / Shares 466.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 47.90 | EPS CAGR: 13.76% | SUE: 1.37 | # QB: 1
Revenue Correlation: -91.37 | Revenue CAGR: -4.37% | SUE: 0.06 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.55 | Chg30d=+31.67% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=1.74 | Chg30d=+10.57% | Revisions=+57% | GrowthEPS=+28.0% | GrowthRev=+4.4%
EPS next Year (2027-12-31): EPS=1.51 | Chg30d=+2.58% | Revisions=+17% | GrowthEPS=-13.2% | GrowthRev=-1.0%
[Analyst] Revisions Ratio: +55% (up=7, down=1)